Seeking Alpha
25 Feb 2026, 22:24 UTC · 36w ago
Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC
Verdict
Headline takes no side. We score EQ +0.20 — slightly bullish.
- Expected · EQ
+0.20slightly bullish
−1 bearish0bullish +1More positive than 50% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.

- biotech
- EQ
- celiac disease
- clinical trials
- cytokine inhibitor
- drug development
- jak inhibitor
- pharma
- ulcerative colitis
Search tags




